Opinion|Videos|August 5, 2024
Combination Regimens with BTK Inhibitors: New Frontiers in CLL Treatment
A panel of experts discuss combination regimens with BTK inhibitors.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- What emerging evidence is there for combination therapies of BTK inhibitors with new and existing therapies to enhance treatment efficacy in CLL?
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Jeff Hunnicutt to Bring Community Oncology Roots to New Role as Navista COO
2
Semaglutide More Than Doubled Likelihood of MASH Resolution
3
Once-Daily Pill Zasocitinib Clears Psoriasis at Toughest Sites
4
Delgocitinib Cream Projected to Save US Health Plans Millions for Chronic Hand Eczema
5